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Sebastian Rodrigo1,3,4, Olivier Dulac1,2,4,6, Francine Chassoux1,2,3,4,7 and Catherine Chiron1,2,3,4,6*Abstract
Background: Statistical parametric mapping (SPM) procedure is an objective tool to analyze 18F-fluoro-2-deoxy-D-
glucose-positron-emission tomography (FDG-PET) images and a useful complement to visual analysis. However,
SPM requires a comparison to control data set that cannot be obtained in healthy children for ethical reasons.
Using adults as controls showed some limitations. The purpose of the present study was to generate and validate a
group of pseudo-normal children as a control group for FDG-PET studies in pediatrics.
Methods: FDG-PET images of 47 children (mean ± SD age 10.2 ± 3.1 years) with refractory symptomatic (MRI-positive,
n = 20) and cryptogenic (MRI-negative, n = 27) focal epilepsy planned for surgery were analyzed using visual and SPM
analysis. Performances of SPM analysis were compared using two different control groups: (1) an adult control group
consisting of healthy young adults (n = 25, 30.5 ± 5.8 years, adult PET template) and (2) a pediatric pseudo-control
group consisting of patients (n = 24, 10.6 ± 3.1 years, children PET template) with refractory focal epilepsy but with
negative MRI and with PET considered normal not only on visual analysis but also on SPM.
Results: Among the 47 children, visual analysis succeeded detecting at least one hypometabolic area in 87% of the
cases (interobserver kappa = 0.81). Regarding SPM analysis, the best compromise between sensitivity and specificity
was obtained with a threshold of p less than 0.001 as an extent of more than 40 voxels. There was a significant
concordance to detect hypometabolic areas between both SPM analyses [kappa (K) = 0.59; p < 0.005] and between
both SPM and visual analyses (K = 0.45; p < 0.005), in symptomatic (K = 0.74; p < 0.005) as in cryptogenic patients (K =
0.26; p < 0.01). The pediatric pseudo-control group dramatically improved specificity (97% vs. 89%; p < 0.0001) by
increasing the positive predictive value (86% vs. 65%). Sensitivity remained acceptable although it was not better (79%
vs. 87%, p = 0.039). The main impact was to reduce by 41% the number of hypometabolic cortical artifacts detected by
SPM, especially in the younger epileptic patients, which is a key point in clinical practice.
Conclusions: This age-matched pseudo-control group is a way to optimize SPM analysis of FDG-PET in children with
epilepsy. It might also be considered for other brain pathologies in pediatrics in the future.
Keywords: PET, FDG, SPM, Children, EpilepsyBackground
Visual inspection of 18F-fluoro-2-deoxy-D-glucose-
positron-emission tomography (FDG-PET) images is
extensively used in pediatric clinical practice, but it
remains subjective and depends on the expertise and
experience of the observer. By contrast, statistical para-
metric mapping (SPM) is an objective and therefore* Correspondence: catherine.chiron@nck.aphp.fr
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reproduction in any medium, provided the origobserver independent method of analysis [1,2], but it
requires comparison to a control data set that is quite
impossible to obtain in healthy children for ethical rea-
sons. Based on FDG-PET in pediatric epilepsy, the
present study proposes to generate and validate a
pseudo-control group of pediatric patients for SPM
studies in children.
PET with 18F-fluoro-2-deoxy-D-glucose or FDG-PET
currently plays a key role in the investigation and man-
agement of patients with refractory focal epilepsy, par-
ticularly when surgery is a therapeutic option [3,4]. Thehis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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regions of interictal hypometabolism are strongly asso-
ciated with the seizure onset zone (also called the epi-
leptogenic zone) in adults as in children, although the
hypometabolism may often extend beyond this zone
[5-7] or occasionally miss it [8]. Findings are usually
analyzed visually, and this is considered to carry power-
ful detecting value, although it is highly variable accord-
ing to the location (temporal/extratemporal) and type
(positive/negative MRI) of epilepsy [9-11]. PET/MRI cor-
egistration also impacts visual detection [12-14]. SPM
proved to be a useful strategy for FDG-PET in adults
with refractory focal epilepsy not only in temporal lobe
cases [5,7,15-19], but also in extratemporal epilepsy and/
or negative MRI, where sensitivity of visual analysis is
lower [20]. For instance, in MRI-negative frontal lobe
epilepsy patients, SPM sensitivity was equivalent or su-
perior to visual analysis [20,21]. As a result SPM is more
and more used as a complementary procedure to study
focal epilepsy in adults.
By contrast, SPM in children with epilepsy remains lim-
ited to a few teams [22-26] and provides discordant results
[14,27]. SPM procedure requires image normalization to a
template before a statistical comparison is done to a con-
trol group. Because of ethical constraints regarding PET in
normal children, pediatric SPM application most often has
to use an adult template and adult controls, but such a
procedure has major limitations. One issue is the differ-
ence in size of the head of adults and children which can-
not be solved with spatial correction and requires the use
of a pediatric template for children below the age of 6
years [23]. Another issue is the major age-related changes
of cerebral glucose metabolism, in cortical as in the sub-
cortical structures, throughout the entire childhood
[28,29]. Regional metabolism increases from birth to
around 4 years up to values over twice the adult values,
which were maintained until the end of the first decade,
when they began to decline and reach adult rates by the
end of the second decade. Metabolism increases earlier in
the sensorimotor and occipital cortex than in the frontal
cortex and increases higher in the cerebral cortex than in
subcortical structures and cerebellum [28]. In the anterior
cingulate cortex and the thalamus in particular, metabol-
ism continues to increase up to 25 years and then remains
relatively stable [29]. Such widespread hypometabolic
changes related to the maturation of cortical and subcor-
tical structures may complicate the interpretation of SPM
results in children when compared to adults (is a given
hypometabolism pathological or physiological?) and may
decrease the sensitivity of detection of hypometabolic
areas using SPM. These issues point out the need of an
age-matched control group.
Despite continuous debate, ethical constraints prevent
investigating healthy children as control subjects forPET studies. To our knowledge, only two authorizations
have been delivered up to now, and they did not include
patients under 6 years of age because they usually need
sedation to be scanned [30,31]. As an alternative, popu-
lations of pediatric patients had therefore to be used as
control groups. A first option was to focus on children
with another pathology and to test the difference with
the pathology to be studied. Using this approach,
Zilbovicius et al. succeeded identifying bitemporal dys-
function with H20
15 PET in autistic children compared
to children with idiopathic mental retardation [32], and
Juhasz et al. identified a medial prefrontal hypometabolic
network with FDG-PET in epileptic children with ag-
gressive behavior compared to non-aggressive ones [33].
However, such control groups cannot be extended to
other studies since they provide PET images with
pathology-related anomalies. A second option was to
generate pediatric control groups from patients with
normal PET images. Two historical studies provided
FDG-PET imaging from respectively sick children con-
sidered retrospectively as normal and pediatric idio-
pathic focal epilepsy, thus permitting to establish the
maturational profile of cortical and subcortical metabol-
ism, but the data are not compatible with current PET
machines [28,34]. The present study provides compatible
data from the epilepsy field.
The aim of this study was to evaluate a pediatric age-
paired pseudo-control group compared to a classical
adult control group in order to optimize the use of SPM
analysis in children with refractory epilepsy.
Materials
We retrospectively studied the 71 consecutive children re-
ferred for FDG-PET examination at our institution during
a 4-year period. Inclusion criteria were the following: diag-
nosis of refractory focal epilepsy, previous extensive work-
up including video-EEG (electroencephalogram) recordings
and MR imaging, and age over 2 years (based on recruit-
ment). The protocol was approved by the institutional eth-
ical standards committee on human experimentation, and
written informed consent was obtained from all guardians
of patients participating in the study.
Clinical findings are summarized in Table 1. Patients’
age at PET ranged from 2.5 to 17.9 years. MRI had been
analyzed by a trained radiologist (LHP) blind to PET
findings. Finding was considered negative (cryptogenic
epilepsy) in 51 cases (72%), whereas a lesion was identi-
fied (symptomatic epilepsy) in the 20 others. Most often
there was a suspicion of focal cortical dysplasia (n = 16).
Other causes were hippocampal sclerosis (n = 1), ische-
mic lesion in the white matter (n = 2), or extensive
cerebral malformation despite focal epilepsy (n = 1).
Lateralization and hypothesis on the location of the seiz-
ure onset zone (SOZ) was based on the scalp video-EEG
Table 1 Clinical findings
All (n = 71) Pseudo-control group (n = 24) Patient group (n = 47)
Age range (years) (mean ± SD) 2.5 to 17.9 (10.2 ± 3.6) 4.5 to 17.9 (10.6 ± 3.1) 2.5 to 17.2 (9.9 ± 3.1)
Sex Females 38 15 23
Males 33 9 24
MRI Negative 51 24 27
Positive 20 0 20
EEG Scalp 71 24 47
Intracranial 15 3 12
SOZ lateralization Right 28 7 21
Left 30 10 20
Undetermined 13 7 6
SOZ location Frontal 21 9 12
Central 19 6 13
FT 5 1 4
Temporal 14 4 10
TPO 7 3 4
Occipital 2 0 2
Undetermined 3 1 2
Epilepsy surgery Performed 21 4 17a
Follow-up >1 year 17 3 14b
Seizure free at 1 year follow-up 13 1 12b
aFive patients required a second operation to complete the resection; bafter the last operation. SD, standard deviation; y, years; EEG, electroencephalogram; SOZ,
seizure onset zone; FT, fronto-temporal; TPO, temporo-parieto-occipital.
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in 15 of them. Seizures were recorded in all patients but
with three presenting active and permanent interictal
spike focus concordant with seizure semiology. SOZ
equally involved right or left hemispheres; lateralization
was undetermined (bilateral in 12 cases, frontal and/or
central, unknown in 1 case) in 18% of the patients. SOZ
mostly affected the frontal or central regions, and the lo-
cation was undetermined in only 4% of the cases. Seven-
teen children have currently been operated on with at
least 1 year follow-up, and 13 of them are seizure-free.
We defined two groups according to MRI and PET
analysis (using both visual and SPM analysis, see Meth-
ods) (Figure 1). Group I (pseudo-control group) com-
prised the 24 children with negative MRI and negative
(normal) PET; group II (patient group) comprised the
remaining 47 children with positive (abnormal) PET (20
had positive MRI, 27 had negative MRI). The clinical
characteristics of groups I and II were similar regarding
age, sex, and lateralization and location of the SOZ
(Table 1). They were compared to an in-house adult
control group (21 healthy adults, aged 21 to 40 years,
mean 30.5 ± 5.8 years), in which PET scans were per-
formed as a research protocol approved by the local eth-
ics committee (CPP Pitié-Salpêtrière, Paris, France) and
written informed consent was obtained.Methods
Image acquisition
18F-FDG PET
Patients were examined using ECAT EXAT HR+
(Siemens Medical Solutions, Munich, Germany) (I2BM,
CEA, Hospital F. Joliot, Orsay, France), a whole-body
scanner that can acquire in 3D mode 63 slices of 2.4-
mm thickness simultaneously. Transverse and axial in-
trinsic spatial resolutions at the center of the field of
view are respectively 4.3 and 4.1 mm. The patients were
investigated in a fasting and resting state, in a quiet,
dimly lit environment. The last seizure had occurred
more than 6 h before PET examination except for 11
patients (less than 1 h in three, between 1 and 6 h in
eight). In 14 patients, 5 mg/kg of pentobarbital were
administered rectally for sedation 1 h before the PET
examination to keep the child still during the exam, a
procedure which does not impact glucose metabolism in
one region specifically [35]. A brain attenuation map
was obtained using a transmission acquisition of three
rod sources of 88Ge for 15 min. Then 3.7 MBq/kg of
18FDG (maximum 180 MBq) was administered intraven-
ously, and the child remained lying in the scanner. At 30
min the patients’ head was precisely re-positioned simi-
lar to transmission using face landmarks and 3D laser,
and the PET dynamic acquisition began, including four
Pseudo-control group (Group I) 
Patient group (Group II) 
Total population 
N=71 
MRI: Negative 
N=51 
MRI : Positive 
N=20 
PET Visual analysis : 
Positive 
N=17
PET Visual analysis : 
Negative 
N=27 
PET Visual analysis : 
Positive 
N=24
PET Visual analysis : 
Negative 
N=3
PET SPM analysis : 
Positive 
N=3 
PET SPM analysis : 
Negative 
N=24 
Figure 1 Flow chart.
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Hanning apodization window (0.5 cycles per pixel cut-
off ) as radial and axial filters providing an image reso-
lution of 6.6 mm in the three directions.
MRI
Brain MRI was obtained for all subjects using a 1.5 Tesla
imager (General Electric Healthcare, Buc Cedex, France) on
the same day. A standard T1-weighted inversion-recovery
fast spoiled gradient recalled (IR-FSPRGR) sequence was
performed with axial orientation using an inversion/echo/
repetition time, with a 1.2-mm slice thickness, as well as
T2-weighted and fluid attenuated inversion recovery
sequences in coronal and/or axial orientation.
Image analysis
MRI images were interpreted by a pediatric neuroradiol-
ogist (LHP) who was blinded to the patients’ identity.
18F-FDG PET visual analysis
18FDG-PET images were analyzed independently by two
experts trained to perform 18F-FDG PET analysis (FA
and FC) after they were given information on the sup-
posed location of SOZ as usually done in the literature.
Transaxial, sagittal, and coronal slices were analyzed
using the local software BrainVisa-Anatomist (brainvisa.
info/index_f.html) after reorientation in either hippo-
campal plane (for temporal lobe epilepsies) or CA-CP
plane (for extratemporal epilepsies). The cortical areas
of 18FDG hypofixation (hypometabolisms) were classified
according to their extent (unilateral lobar, unilateral
multilobar, hemispheric, and bilateral), intensity (discrete,moderate, or severe), and location among the five left
and right following cortical regions systematically ana-
lyzed (ten regions per patient): frontal, central, parietal,
temporal or insular, and occipital. A hypometabolic area
was considered significant when seen on more than one
slice (3.5-mm thickness) and had moderate to severe in-
tensity. To assess the concordance between both experts,
a kappa test was performed. In patients with discordant
results, images were reviewed by both experts to reach a
consensus.
18F-FDG PET SPM analysis
It was achieved using MATLAB7 (The Mathworks, Inc.,
Natick, MA, USA) and the statistical parametric mapping
software SPM5 (www.fil.ion.ucl.ac.uk). Individual analysis
was based on the contrast patient < controls (hypometabo-
lism), using a 2-sample t test and age as covariate. The
resulting SPM (t) statistic threshold was at three levels:
p < 0.001 (uncorrected), p < 0.01 (uncorrected), and p < 0.05
(corrected), and at three extents of contiguous voxels per
cluster of 40, 100, and 200, as previously reported [27].
Similarly to the visual analysis, the significant hypome-
tabolic clusters were classified according to their loca-
tion among the ten previously mentioned regions. We
defined as true hypometabolic clusters the significantly
abnormal clusters having a cortical location concordant
with visual analysis (hypometabolic areas) or being
clinically relevant when visually absent (i.e., on the same
side and with the same location as SOZ); the remaining
abnormal clusters were defined as artifacts. True hypo-
metabolic clusters and artifacts are retrospectively
defined patients with true positive and false positive PET
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metabolic clusters located within the interhemispheric
fissure, but they were excluded from the analysis since
they were extracortical.
Groups I and II were analyzed as follows (Figure 1):
Group I (Pseudo-control group). To compose this group,
we initially considered the 27 MRI-negative children with
normal PET at visual analysis. We normalized PET
images using an in-house pediatric template (44 children
with negative MRI, including 28 with focal epilepsy and
16 with degenerative-like neuro-Langerhans histiocytosis,
mean age 10 ± 3 years) [36]. We compared each child to
the rest of the group (n = 26) in order to detect any
residual cluster with abnormal metabolism and therefore
to reach the lowest inter-subject variability as possible
[37]. For this analysis we selected the threshold p < 0.001
and voxel size greater than 40 (see “Results”), and we also
studied the contrast patient > controls (hypermetabolism)
using the same parameters as for hypometabolism. True
hypo and/or hypermetabolic clusters were found in three
children; thus, the definite pseudo-control group was
restricted to the 24 children without any relevant
metabolic abnormality after this 2-step procedure.
Group II (Patient group). This group comprised the 44
children with abnormal PET at visual analysis and the
three patients excluded from the previous group. Two
successive SPM analyses (SPM-A and SPM-P) were
performed using two different control groups: (1) SPM-A,
PET images were normalized using the in-house adult
control template and statistics was compared each of the
47 pediatric patients to this adult control group; (2) SPM-
P, PET images were normalized using the same in-house
pediatric template as for group I and was statistics
compared each of the 47 pediatric patients to the pseudo-
control group (n = 24).
Based on the true hypometabolic clusters and the
hypometabolic artifacts on SPM, we determined the
sensitivity, the specificity, and the predictive value of
SPM-A and SPM-P analyses to detect significant hypo-
metabolic areas when compared to a standard includ-
ing visual analysis and clinical relevance. Sensitivity and
specificity were compared between SPM-A and SPM-P
using McNemar’s test.
Concordance between analysis procedures
It was assessed using the kappa test. The three proce-
dures (visual, SPM-P, and SPM-A) were considered con-
cordant when they were all negative or when the most
intense hypometabolic area on visual analysis corre-
sponded to the most significant hypometabolic cluster
on SPM analyses. Concordance was complete when the
number of hypometabolic regions involved was similarwithin the three procedures, otherwise it was partial.
The procedures were considered discordant in the other
conditions, i.e., when one of them did not disclose any
metabolic abnormality that the two others did. We stud-
ied between-procedure concordance in the whole popu-
lation of patients (group II) and in cryptogenic versus
symptomatic ones.Results
Visual analysis
First visual analysis found a concordance between both
experts for 61 children (86%) (kappa = 0.8113, p < 0.05);
28 of them had no abnormality, and the remaining 33
had at least one hypometabolic area. The extent, loca-
tion, and intensity of hypometabolic areas were also
concordant between both experts. In nine other chil-
dren, discordances involved mild to moderate hypome-
tabolism: as a result, they were differently classified as
having either no or unilateral lobar hypometabolism
(five cases) and either unilateral or bilateral hypometa-
bolism (four cases). In only one remaining child, the
expert’s findings were totally discordant (right lobar
against left multilobar).
After a second visual analysis of the discordant cases,
a consensus was reached: finally there were 30 children
without any hypometabolism (negative/normal PET) [27
with negative MRI, the three others having either a
white matter ischemic lesion (two cases) or an unusual
pattern of the precentral gyrus (one case)] and 41 chil-
dren (58%) with at least one hypometabolic area
(positive/abnormal PET) (Figure 1). This rate reached
87% in the patient group. Extent of hypometabolism was
unilateral lobar in 18 cases, unilateral multilobar in 14,
hemispheric or bilateral in 9. Among the 470 regions
analyzed (10 regions in 47 patients), 86 (18%) were
hypometabolic, and the intensity was more often severe
(64/86) than moderate (22/86). The most frequent loca-
tion was temporal due to the high frequency of temporal
involvement in the multilobar hypometabolic areas
(Figure 2).
Among the 86 detected hypometabolic regions, 48
(56%) were concordant with the SOZ (25 in sympto-
matics, 23 in cryptogenics): 32 (37%) of them were
superimposed with SOZ (half were temporal) and 16
others (19%) were more extended than SOZ and
involved adjacent cortical areas. In 19/86 regions (22%),
the location of visual hypometabolism was different
from the supposed location of the SOZ (four in symp-
tomatics, 15 in cryptogenics). In the remaining 19
regions (22%), either the SOZ location was undeter-
mined (nine regions in 2 patients) or was bilateral with
a contralateral hypometabolism (ten regions in 6
patients).
Figure 2 Cortical location of the hypometabolic areas. X axis
presents the number of hypometabolic areas using visual analysis
(n = 86) and of hypometabolic clusters (true hypometabolic areas
and artifacts) using SPM-P (n = 83) and SPM-A (n = 120), according
to their regional location on the cortex: F, frontal; C, central or
opercular; P, parietal; T, temporal or insular; O, occipital. Y axis
presents the number of hypometabolic areas among the 470
regions visually analyzed (47 patients, ten regions/patient). Notice
that visual analysis is equal or superior to SPM to identify a
hypometabolic area in any region, and both SPM procedures are
quite equivalent to identify a true hypometabolic cluster in any
region, but SPM-A identifies more artifacts than SPM-P, particularly
in the frontal and temporal cortices, the most frequent
hypometabolic locations.
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Among the 24 children retained within this group, SPM-P
analysis was completely negative in 15. Artifacts were
found in the nine remaining children, but they were small
(less than 200 voxels) and disseminated on the whole cor-
tex (Table 2). By contrast, in the three additional children
transferred from group I to group II because their PETTable 2 Artifact localization in nine patients from group I
(pediatric pseudo-control group, n = 24) using SPM-P
procedure
Hypometabolism Hypermetabolism
Patientsa - 5/9 - 6/9 -
Location Side Clusters (voxels)a Z max Clusters (voxels) Z max
Occipital R 2 (76 to 188) 4.84 2 (68 to 78) 4.14
L 1 (115) 4.49 8 (45 to 156) 4.22
Ins-temp R 3 (59 to 181) 4.13 - -
L 2 (56 to 65) 3.56 3 (87–183) 4.19
Parietal R 1 (66) - - -
L - - - -
Central R 1 (68) 3.96 - -
L - 1 (46) 3.67 -
Frontal R - - 2 (126 to 175) 4.28
L - - 1 (191) 4.60
Total - 11 4.84 17 4.60
anumbers; R right; L left; Ins-temp insulo-temporal.images were found abnormal at SPM-step analysis and the
artifacts included more than 400 voxels (1 child with one
hypo-, 1 other child with one hyper-, and 1 with several
hypo- and hypermetabolic clusters respectively).
SPM analyses of the patient group (group II)
Among the three p value thresholds tested, the best com-
promise between sensitivity and specificity was obtained
for p < 0.001 for both SPM-A and SPM-P analyses
(Table 3). Among the 3 voxel extents tested, the best com-
promise between sensitivity and specificity at p < 0.001
was obtained for 40 voxels for both SPM-A and SPM-P
analyses (Table 3). These two thresholds were therefore
selected for the following results.
SPM-A analysis found significant hypometabolic clus-
ters in 120 (25%) out of the 470 cortical regions studied:
78/120 (65%) corresponded to true hypometabolic clus-
ters (74 were concordant with visual analysis; for the
remaining four, the hypometabolic cluster was clinically
relevant although visually normal) and the remaining 42
were hypometabolic artifacts. By contrast, SPM-A failed
to detect any hypometabolic cluster in 12 regions which
were hypometabolic on visual analysis. As a result, our
SPM-A procedure had a sensitivity of 87%, specificity of
89%, positive predictive value of 65%, and negative pre-
dictive value of 95%.
SPM-P analysis found significant hypometabolic clusters
in 83 (18%) out of the 470 cortical regions studied: 71/83
(86%) corresponded to true hypometabolic clusters (68
were concordant to visual analysis, the remaining three
were visually normal but clinically relevant), and the
remaining 12 were hypometabolic artifacts. By contrast,
SPM-P failed to detect any hypometabolic cluster in 19
regions which were hypometabolic on visual analysis. As a
result, our SPM-P procedure had a sensitivity of 79%, spe-
cificity of 97%, positive predictive value of 86%, and a
negative predictive value of 95%.
Sensitivity was moderately better using SPM-A than
SPM-P (p = 0.039, Mac Nemar test). By contrast, specifi-
city was dramatically higher using SPM-P than SPM-A
(p < 0.0001). This was due to the higher positive predict-
ive value using SPM-P, which markedly reduced the
number of hypometabolic artifact detected, whereas the
negative predictive value was equivalent using both pro-
cedures. Comparing SPM-A and SPM-P procedures, the
number of artifacts tended to be less in younger children
(especially under 6 years of age) using SPM-P (Figure 3).
Additional artifacts were found within the interhemi-
spheric fissure: 13 when using SPM-A, of which only 4
persisting when using SPM-P.
Artifacts did not result exclusively from the normalization
procedure; the age-related changes may also play a role. In-
deed, artifacts did not disappear when analyzing pediatric
patients using the adult control group normalized with the
Table 3 Sensitivity and (specificity) of SPM-A and SPM-P analysis using the different thresholds
Voxel extent >40 voxels >100 voxels >200 voxels
SPMp p < 0.0001
a p < 0.001a p < 0.05b p < 0.0001a p < 0.001a p < 0.05b p < 0.0001a p < 0.001a p < 0.05b
SPM-A 0.60 (0.97) 0.87 (0.89) 0.62 (0.92) 0.41 (0.99) 0.82 (0.86) 0.56 (0.93) 0.39 (0.99) 0.71 (0.94) 0.56 (0.75)
SPM-P 0.56 (0.98) 0.79 (0.97) 0.56 (0.97) 0.47 (0.99) 0.73 (0.97) 0.55 (0.98) 0.39 (0.99) 0.62 (0.98) 0.59 (0.99)
aUncorrected; bcorrected.
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to SPM-A procedure, but increased compared to SPM-P.
Concordance of analysis procedures
Visual analysis, SPM-P and SPM-A were concordant in
36 patients (77%), being all negative in 3 of them, and
positive in the remaining 33 (80% of the 41 patients with
positive visual analysis) (Table 4). Concordance was
complete in 28/33 (68%), with the most significant true
hypometabolic cluster on SPM having the same lobar
and intra-lobar location and including the same number
of regions whatever the method of analysis (Figure 4).
Concordance was partial in the remaining five patients,
with more hypometabolic regions detected with visual
analysis in four and with SPM in one. Visual analysis,
SPM-P, and SPM-A were discordant in the remaining 11
patients (23%). In two cases both SPM procedures dis-
closed the same true hypometabolic cluster, but visualFigure 3 Hypometabolic artifacts observed in patient group using SP
group (n = 47) using SPM-A analysis (adult control group) and SPM-P analy
Y axis presents the number of hypometabolic artifacts (false positive results
represents the number of patients at the different ages. Notice that artifact
found in patients under 6 years old using SPM-P.analysis was negative. In nine cases SPM-P did not de-
tect any abnormality whereas visual analysis, SPM-A, or
both did in respectively 3, 1, and 5 cases with the same
localization. Finally, kappa test gave a significant con-
cordance of 0.448 ± 0.084 (p < 0.005) between the three
analysis procedures, 0.598 ± 0.140 (p < 0.005) between
both SPM methods, and 0.427 ± 0.194 (p < 0.005) or
0.330 ± 0.158 (p = 0.007) between visual analysis and re-
spectively, SPM-A or SPM-P.
Regarding the 20 MRI-positive patients, the three proce-
dures were concordant in 18 (90%) (kappa = 0.739 ± 0.129;
p < 0.005), being all positive in 16 and all negative in two,
and they were discordant in the remaining two with nega-
tive SPM-P. Concordance between visual analysis and SPM
procedure reached 0.773 ± 0.216 (p < 0.005) for SPM-A
and 0.828 ± 0.166 (p < 0.005) for SPM-P. Regarding the 27
MRI-negative patients, the three procedures were concord-
ant in 18 (67%) (kappa = 0.264 ± 0.111; p < 0.01), being allM-A and SPM-P analysis. Hypometabolic artifacts observed in patient
sis (pediatric pseudo-control group). X axis presents the ages (in years).
) using SPM-A (lozenges) and SPM-P (circles) analysis. The broken line
s are observed less frequently using SPM-P than SPM-A, and none was
Table 4 Patients with at least one true hypometabolism
using visual, SPM-P, and SPM-A analysis
Visual analysis
SPM-P SPM-A Positive Negative
Positive Positive 33 (17C, 16S) 2 (2C, 0S)
Negative Positive 5 (4C, 1S) 1 (0C, 1S)
Negative 3 (3C, 0S) 3 (1C, 2S)
Total 41 (24C, 17S) 6 (3C, 3S)
SPM-P, SPM analysis using the pediatric pseudo-control group; SPM-A, SPM
analysis using the adult control group; C, cryptogenic (MRI-negative) patients;
S, symptomatic (MRI-positive) patients.
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cordant in the remaining nine with negative SPM-P in
seven of them. Concordance between visual analysis and
SPM procedures did not reach significance.
Discussion
The goal of this study was to evaluate the performances
of SPM analysis of FDG-PET in children using an age-
matched pseudo-control group of epileptic patients with
robustly negative imaging versus classical healthy young
adult controls. Both SPM analyses achieve a similar rate
of detection of hypometabolic clusters and perform as
well as visual analysis, not only in MRI-positive patients
but also in MRI-negative ones. Although the sensitivity
of SPM is not increased using pediatric vs. adult controls
(79% vs. 87%), specificity is increased (97% vs. 89%) due
to the reduction of the number of hypometabolic arti-
facts detected. As a result the positive predictive value of
the method rises from 65% to 86%. That provides a rele-
vant clinical impact especially in the younger children.
Visual inspection of FDG-PET images is extensively
used in clinical epilepsy practice and remains the referenceFigure 4 Comparative results using SPM-A, SPM-P, and visual analyse
(pediatric pseudo-control group) and visual analyses in a 4 year old patient
(SOZ) in the left insula, visual analysis (image C) shows a left insular hypom
hypometabolic cluster in the same area. SPM-A (image A, SPM glass brain)
hypometabolic artifacts mainly located within the frontal cortex, ipsi- and cmethod of analysis in children [14,27]. The hypometabolic
areas detected have been proved to include the seizure
onset zone, although they usually are more extended and
do not delineate it [6,8]. The localizing value of visual PET
analysis varies from 36% to 73% in extratemporal cases,
depending whether MRI is negative or not [9,20], and
reaches 90% exclusively in temporal lobe cases [26]. This
detection value can be improved, particularly in extratem-
poral epilepsy with negative MRI, using PET/MRI coregis-
tration [12,13]. That has been confirmed by intracranial
EEG and post-operative data. The present 56% detection
rate of relevant hypometabolic areas is therefore in ac-
cordance with the literature, if one considers that we did
not use coregistration and that the series mostly comprises
MRI-negative patients and children with extratemporal
epilepsy. In addition, the ability to detect a hypometabolic
area visually is subjective and depends on the expertise
and experience of the observer. Most reported series tend
to limit this bias by achieving a consensus between closely
performing readers, as we presently did with a first con-
cordance of 0.81.
By contrast, SPM analysis is observer independent
[1,2]. Taking the whole brain into account, it allows
assessing the spatial extent and location of the abnormal
site on the brain map with no a priori hypothesis. Ini-
tially dedicated to the comparison of data sets among
groups of subjects, SPM method also proved to be reli-
able for quantitative analysis of individual FDG-PET
scans in various neurological disorders, including epi-
lepsy [37]. SPM analysis has been widely applied to the
study of adults with epilepsy, with thresholds varying
from p < 0.001 (uncorrected) to p < 0.05 (corrected) and
>20 voxels to >250 voxels [5,7]. Since SPM showed com-
parable sensitivity to visual assessment, it is considereds. Comparative results using SPM-A (adult control group), SPM-P
. In this 4-year-old patient with positive MRI and seizure onset zone
etabolic area (axial slice). SPM-P (image B, SPM glass brain) identifies a
also identifies this cluster, but also shows several additional
ontralaterally.
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as well as in extratemporal lobe epilepsy and in lesional
as well as in non-lesional cases [5,7,12,15,16,38].
In children, experience with SPM in epilepsy is more
limited. Only one study formally assessed the role of stat-
istical threshold on sensitivity and specificity [27]: they
found p < 0.001 as the best compromise, as we presently
do. Based on young adults as controls, the results are not
univocal. De Tiege et al. did succeed detecting areas of re-
mote inhibition in children aged 5 to 11 years with a par-
ticular epileptic encephalopathy and to see them vanish
when epilepsy and cognitive deficits recover [24,39,40].
Some authors showed a high SPM performance (86%) for
correct localization of the seizure onset zone in adoles-
cents (12 to 15 years) [26], but others achieved a rate of
only 13% in children from the age of 3 [14]. In another
series, the same procedure gave an SPM sensitivity of 74%
in children over 6 years old [27], whereas it failed in chil-
dren under 6 years of age due to a significant proportion
of artifacts [23]. We also found a high number of such
false positive hypometabolic clusters when using an adult
template, at a threshold stringent for such an individual
SPM analysis [12]. One main issue is the different sizes of
the head of adults and young children [23]. We confirm
here that this artifact rate is higher in the younger ages
and can be reduced by using a pediatric template [36]. An-
other potential advantage of a pseudo-normal epilepsy
group could be that the potential effect of the antiepileptic
drugs is largely cancelled out since both the patients and
the control groups were on antiepileptic medication [35].
To generate even better templates, one could speculate on
data from other pathologies that justify whole-body PET
scanning but may respect the brain, like pediatric lymph-
oma, for example [41].
In order to deal with the pediatric controls the closest
to “normals”, we confirmed PET negativity using the
Signorini’s method [37]: each data set of the pseudo-
control group was compared to the rest of the group
using SPM. The complete procedure excluded three
additional children. Our main result is a gain of specifi-
city and this pediatric procedure reaches the highest
rates ever reported in epilepsy for SPM. Conversely, the
predictive positive value is improved, thus decreasing
the number of artifacts and optimizing the clinical rele-
vance of SPM analysis compared to the classical adult
procedure. We assume that these advantages of pediatric
SPM can compensate the slightly decreased sensitivity
compared to adult SPM (79% vs. 87%). Note that these
rates of sensitivity and specificity apply to SPM analysis
and not to FDG-PET in general, since we excluded from
their calculation the major part of negative cases. Never-
theless, this method was robustly able to identify some
clinically relevant hypometabolic areas missed by visual
analysis in 6% of cases.Although our template presents with the usual balance
of specificity versus sensitivity, we recently showed the
whole procedure to be beneficial also in multifocal child-
hood epilepsy when visual PET analysis fails to detect bi-
lateral abnormalities, as in school-age children with a
fever-induced epileptic encephalopathy [42].
Conclusion
Such a pediatric SPM procedure is a way to optimize
SPM analysis of FDG-PET in children with epilepsy, use-
ful for clinical purpose and for research. It might also be
considered for other brain pathologies in pediatrics in
the future.
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